The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee concluding last year ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

The FDA on Monday approved an experimental drug that aims to slow the progression of Alzheimer's disease, despite the fact that a key FDA panel late last year said that questions remain about its ...

COLUMBUS, Ga. (WRBL) – Today the second patient in the world, and the first in a non-university-based facility, began infusion with a new FDA proven drug, called Aduhelm, for the treatment of early ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Medicare members could face barriers to accessing Biogen’s new Alzheimer’s drug, Aduhelm, due to the treatment’s high cost. The drug, which is currently priced at $56,000 a year, could surpass $5 ...

WASHINGTON (AP) — The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with ...

COULD HELP OTHERS. TERRY BECKER IS A RETIRED FIFTH GRADE TEACHER, BUT THE YOUNG PEOPLE GETTING HIS ATTENTION THESE DAYS ARE HIS FOUR GRANDDAUGHTERS. OUR DAUGHTER AND HER HUSBAND, AND TWO GIRLS. THEY ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...